Literature DB >> 16900514

Therapeutic strategy for patients with pN0 gastric carcinoma.

Chikara Kunisaki1, Hiroshi Shimada, Masato Nomura, Goro Matsuda, Yuichi Otsuka, Hidetaka Ono, Hirotoshi Akiyama.   

Abstract

BACKGROUND AND OBJECTIVES: The prognosis for patients with pN0 gastric cancer is moderately hopeful (expected 5-year survival: 80%). However, the relevant prognostic factors and most appropriate surveillance protocol have not been identified.
METHODS: We investigated 733 gastric cancer patients without lymph node metastasis for prognostic factors by uni- and multi-variate analysis and by documenting causes of death and recurrence patterns.
RESULTS: Univariate analysis revealed that age, tumor location, macroscopic appearance, tumor diameter, invasion depth, lymphatic invasion, and venous invasion affected prognosis. Multivariate analysis showed that age (> or = 60 years), ill-defined macroscopic appearance, and undifferentiated histological type independently reduced survival rates. Age (> or = 60 years) and undifferentiated histological type adversely influenced prognosis in 507 early gastric cancer patients whereas ill-defined macroscopic appearance adversely affected prognosis in 226 advanced cancer patients. Recurrence patterns in these patients were similar to those produced by lymph node metastasis. The predominant recurrence pattern was peritoneal dissemination, observed 2-3 years post-resection.
CONCLUSIONS: This study identified adverse prognostic factors in pN0 gastric cancer patients. Randomized controlled studies of adjuvant chemotherapy are necessary to assess whether such therapy is beneficial for patients with adverse prognostic factors. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16900514     DOI: 10.1002/jso.20601

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Prognostic impact of venous invasion in stage IB node-negative gastric cancer.

Authors:  Ippeita Araki; Kei Hosoda; Keishi Yamashita; Natsuya Katada; Shinichi Sakuramoto; Hiromitsu Moriya; Hiroaki Mieno; Akira Ema; Shiro Kikuchi; Tetuo Mikami; Masahiko Watanabe
Journal:  Gastric Cancer       Date:  2014-04-01       Impact factor: 7.370

2.  Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer.

Authors:  Ippeita Araki; Marie Washio; Keishi Yamashita; Kei Hosoda; Akira Ema; Hiroaki Mieno; Hiromitsu Moriya; Natsuya Katada; Shiro Kikuchi; Masahiko Watanabe
Journal:  Surg Today       Date:  2017-12-18       Impact factor: 2.549

Review 3.  Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors.

Authors:  Yanming Zhou; Feng Yu; Lupeng Wu; Feng Ye; Leilei Zhang; Yumin Li
Journal:  Med Sci Monit       Date:  2015-07-02

4.  Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series.

Authors:  Gian Luca Baiocchi; Sarah Molfino; Carla Baronchelli; Simone Giacopuzzi; Daniele Marrelli; Paolo Morgagni; Maria Bencivenga; Luca Saragoni; Carla Vindigni; Nazario Portolani; Maristella Botticini; Giovanni De Manzoni
Journal:  World J Gastroenterol       Date:  2017-12-07       Impact factor: 5.742

5.  Extensive small bowel metastasis and peritoneal dissemination 1 year following curative gastrectomy for T1N1 gastric cancer: A case report.

Authors:  Shengxian Fan; Min Feng; Meng Wang; Wenxian Guan
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.